ProQR Therapeutics will showcase clinical and preclinical progress of its RNA editing therapies AX-0810 and AX-0811 at upcoming 2026 conferences including TIDES Europe, The Liver Meeting, and Nature Conferences RNA at the Bench and Bedside. AX-0810 Phase 1 data, highlighting safety and target engagement, will be featured in multiple presentations, while AX-0811, a next-generation therapy developed using AI, is in Phase 1 trials with initial data expected in early 2027. These presentations underline ProQR's advancements in RNA editing technology aimed at treating cholestatic disease and other conditions.
ProQR Therapeutics' clinical and preclinical progress is the subject, with Pluang market data providing context. Of 150 priced Health-sector US stocks on Pluang, 42 rose and 97 fell today. Notable movers include Dyne Therapeutics Inc. at USD 16.42 with a -3.07% change and a typical hold time of 6 days, Sana Biotechnology Inc. at USD 2.53 with a +2.43% change and a 31% Sell / 69% Buy order split, as of Oct 28, 2026 19:11 WIB.
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
The Legacy Lab by Team One released its 2026 Legacy Makers 100 list, identifying brands consumers trust to have their best interests at heart and remain relevant long-term. St. Jude Children's Research Hospital topped the list for the second year. Th...
Circuit Mind has introduced AVE (Agentic Verification Engine), an AI-powered application that verifies printed circuit board (PCB) schematics against datasheets and internal design rules to catch errors early and avoid expensive respins. AVE compleme...
Grabar Law Office is investigating claims against officers and directors of Erasca, Planet Fitness, PROCEPT BioRobotics, and The Simply Good Foods Company for alleged breaches of fiduciary duties. The investigations focus on misleading statements and...
